Concepedia

Switching Antipsychotics

Switching Antipsychotics is a clinical pharmacotherapy strategy involving the substitution of one antipsychotic medication for another with the aim of improving therapeutic efficacy, reducing adverse effects, or addressing treatment non-response in patients with schizophrenia spectrum disorders.

477

Publications

18.3K

Citations

2.1K

Authors

892

Institutions

Publications per year

2017–2026

69

Parents

Publications

477

Poor Antipsychotic Adherence Among Patients With Schizophrenia: Medication and Patient Factors

Marcia Valenstein, F. C. Blow, Laurel A. Copeland et al. · Schizophrenia Bulletin · 2004 · 279 citations

, , +17

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

Daniel E. Casey, William H. Carson, Anutosh Ranjan Saha et al. · Psychopharmacology · 2003 · 252 citations

, , +12

Does switching to a new antipsychotic improve outcomes?

Robert A. Rosenheck, Sonia M. Davis, Nancy H. Covell et al. · Schizophrenia Research · 2008 · 234 citations

, , +10

Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine

Florian Schlagenhauf, Georg Juckel, Michael Koslowski et al. · Psychopharmacology · 2007 · 208 citations

, , +16

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

René S. Kahn, Covadonga M. Díaz‐Caneja, Marinus J.C. Eijkemans · The Lancet Psychiatry · 2018 · 197 citations · Full text

, , +16

1–5 of 477

Authors

2.1K

  1. PJ
    Peter J. Weiden

    University of Illinois Chicago, United States

    12 publications · 666 citations

    11

    h-index

  2. CU
    Christoph U. Correll

    Zucker Hillside Hospital, United States

    10 publications · 445 citations

    10

    h-index

  3. AL
    Antony Loebel

    Vion Pharmaceuticals (United States), United States

    9 publications · 330 citations

    9

    h-index

  4. DT
    David Taylor

    King's College London, United Kingdom

    8 publications · 278 citations

    8

    h-index

  5. RG
    Robin G. McCreadie

    Crichton Royal Hospital, United Kingdom

    7 publications · 360 citations

    7

    h-index

1–5 of 2.1K

Institutions

892

  1. Eli Lilly (United States)

    Indianapolis, United States

    16 h-index

    59 publications

    2.8K citations

  2. King's College London

    London, United Kingdom

    12 h-index

    55 publications

    2.2K citations

  3. Zucker Hillside Hospital

    New York, United States

    12 h-index

    19 publications

    931 citations

  4. Janssen (United States)

    Hopewell, United States

    12 h-index

    43 publications

    1.7K citations

  5. University of Toronto

    Toronto, Canada

    11 h-index

    24 publications

    1K citations

  6. Janssen (Belgium)

    Beerse, Belgium

    11 h-index

    20 publications

    530 citations

  7. Charité - Universitätsmedizin Berlin

    Berlin, Germany

    10 h-index

    40 publications

    3.3K citations

  8. Centre for Addiction and Mental Health

    Toronto, Canada

    10 h-index

    25 publications

    1.1K citations

1–8 of 892

Venues

  1. The Journal of Clinical Psychiatry

    38 publications · 1.8K citations

    26

    h-index

  2. PubMed

    Repository · 44 publications · 1.8K citations

    24

    h-index

  3. Journal of Clinical Psychopharmacology

    28 publications · 879 citations

    18

    h-index

  4. International Clinical Psychopharmacology

    22 publications · 727 citations

    17

    h-index

  5. Acta Psychiatrica Scandinavica

    13 publications · 503 citations

    12

    h-index

1–5